Alimera Sciences reported $11.4M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Alimera Sciences ALIM:US $ 11.4M 1.09M
Applied Genetic Technologies AGTC:US $ 21.71M 2M
Bayer BAYN:GR € 28727M 801M
Insmed INSM:US $ 112.5M 12.84M
Novartis NOVN:VX SF 29880M 247M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M